CIK 0001574094
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
RenovoRx, Inc.
Sign in to watch- Ticker
- RNXT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 271448452
- Phone
- +1 408-800-2649
- Business address
- 2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW, CA, 94040
- Open-market buys, last 90 days
- $46,485
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$46,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Macfarlane K. Angela Director | Grant or award · Stock Options (right to buy) | +55,924 | 55,924 | ||
| 2025-10-01 | Macfarlane K. Angela Director | Grant or award · Stock Options (right to buy) | +47,640 | 47,640 | ||
| 2024-10-01 | Macfarlane K. Angela Director | Grant or award · Stock Options (right to buy) | +25,099 | 25,099 | ||
| 2024-01-26 | Macfarlane K. Angela Director | Purchase | +40,983 | 40,983 | ||
| 2024-01-26 | Macfarlane K. Angela Director | Purchase · Warrant Shares | +40,983 | 40,983 | ||
| 2023-10-01 | Macfarlane K. Angela Director | Grant or award · Stock Options (right to buy) | +25,099 | 25,099 | ||
| 2022-10-01 | Macfarlane K. Angela Director | Grant or award · Stock Option (right to buy) | +25,099 | 25,099 | ||
| 2022-03-10 | Macfarlane K. Angela Director | Grant or award · Stock option (right to buy) | −4,582 | 4,582 |
Page 1 of 1 · 8 trades